Streetbeat News

CBWTF

Auxly Cannabis Group Inc.

https://www.auxly.com/

Industry

Commodity Contracts Dealing

Open

0.05

Mkt cap

70M

Volume

320K

High

0.05

P/E Ratio

-1.06

52-wk high

0.07

Low

0.05

Div yield

N/A

52-wk low

0.01

On January 23, 2024, several cannabis stocks experienced significant price movements. MedMen Enterprises led the gainers with a 999900.00% increase, closing at $0.01, while Pharmadrug led the losers with a 25.23% decrease, closing at $0.03. Notable gainers included Cann Gr, Khiron Life Sciences, and Canopy Growth, with increases of 125.92%, 59.09%, and 5.22% respectively. Among the losers, Greenlane Holdings and OrganiGram Holdings saw declines of 5.20% and 3.96%. The article was generated by Benzinga's automated content engine.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on January 19, 2024. EVIO led the gainers with a 9900.00% increase, while Rocky Mountain High topped the losers with a 21.62% decline. Notable gainers included Genetic Technologies, OrganiGram Holdings, and Cara Therapeutics, with increases of 42.16%, 10.72%, and 4.80% respectively. Among the losers, Corbus Pharmaceuticals and Greenlane Holdings saw declines of 4.91% and 3.32%.

Portfolio Pulse from Benzinga Insights

January 19, 2024 | 9:30 pm

On January 17, 2024, several cannabis stocks experienced significant price movements. AusCann Group Holdings led the gainers with a 187.50% increase, while MedMen Enterprises and GreenGro Technologies were the biggest losers, both dropping by over 99%. Other notable gainers include Khiron Life Sciences and Maple Leaf Green World, with increases of 54.29% and 32.45%, respectively. Among the losers, 22nd Century Group and OrganiGram Holdings saw declines of 14.72% and 7.89%. The movements reflect the volatile nature of the cannabis market.

Portfolio Pulse from Benzinga Insights

January 17, 2024 | 9:30 pm

The article lists the cannabis stocks that experienced significant gains and losses on January 16, 2024. Notable gainers include MedMen Enterprises, C21 Investments, and 22nd Century Group, with increases of 66.67%, 19.62%, and 14.92% respectively. On the losing side, Khiron Life Sciences and Global Hemp Group saw sharp declines of 49.64% and 44.60%. The article reflects the volatility in the cannabis market and may influence investor sentiment.

Portfolio Pulse from Benzinga Insights

January 16, 2024 | 9:30 pm

Marijuana stocks saw significant movement on January 15, 2024, with Khiron Life Sciences leading the gainers with a 152.73% increase, while MedMen Enterprises experienced a steep decline of 95.71%. Other notable gainers include Global Compliance, CordovaCann, and RIV Capital. The losers' list was topped by AusCann Group Holdings with a 58.82% drop, followed by EnWave and Auxly Cannabis Group.

Portfolio Pulse from Benzinga Insights

January 15, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on January 12, 2024. Khiron Life Sciences led the gainers with a 152.73% increase, while MedMen Enterprises saw a dramatic 95.71% drop. Other notable gainers include Global Compliance and CordovaCann. Among the losers, AusCann Group Holdings also faced a steep decline. The volatility in these stocks reflects ongoing developments in the cannabis industry.

Portfolio Pulse from Benzinga Insights

January 12, 2024 | 9:30 pm

On January 11, 2024, several cannabis stocks experienced significant movements. Notable gainers included Heritage Cannabis Holding, Blueberries Medical, OrganiGram Holdings, and others, with increases ranging from 3.12% to 26.58%. Conversely, several companies faced declines, with Global Compliance leading the losers, followed by Rocky Mountain High, CLS Holdings USA, and others, with decreases ranging from 3.07% to 16.57%. The article lists the closing prices and percentage changes for each mentioned company.

Portfolio Pulse from Benzinga Insights

January 11, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on January 10, 2024. Choom Holdings, EVIO, Global Hemp Group, Global Compliance, Cannabix Technologies, Body and Mind, Pharmadrug, Neptune Wellness Solutions, and Trees saw gains, with Choom Holdings leading with a 9900% increase. Conversely, Acacia Diversified Holdings led the losers with a 99% decline, followed by significant losses in Cann Gr, Khiron Life Sciences, CordovaCann, Elixinol Wellness, 1933 Industries, Item 9 Labs, Affinor Growers, 4Front Ventures, C21 Investments, Heritage Cannabis Holding, Cresco Labs, Leafbuyer Techs, Trulieve Cannabis, Eastside Distilling, Curaleaf Holdings, Cara Therapeutics, Indiva, Auxly Cannabis Group, RIV Capital, Tilray Brands, Greenlane Holdings, iAnthus Capital Holdings, Psychemedics, SNDL, and SOL Global Investments.

Portfolio Pulse from Benzinga Insights

January 10, 2024 | 9:30 pm

The marijuana stock market saw significant movements on January 9, 2024, with a mix of gainers and losers. Notable gainers included AusCann Group Holdings, Rocky Mountain High, and Item 9 Labs with substantial percentage increases in their share prices. On the other hand, Australis Capital and Choom Holdings experienced dramatic declines, with Australis Capital shares closing down 100%. Other notable losers included Tilray Brands, Canopy Growth, and SNDL with significant percentage decreases. This market activity reflects the volatile nature of the marijuana industry stocks.

Portfolio Pulse from Benzinga Insights

January 09, 2024 | 9:30 pm

Marijuana stocks experienced significant movement on a recent Friday, with Choom Holdings leading the gainers with a 9900.00% increase, while EVIO was the top loser, dropping 98.00%. Other notable gainers include Affinor Growers, Blueberries Medical, and Indiva. On the losing side, Global Hemp Group and Pharmadrug also saw notable declines. The volatility in these stocks reflects the dynamic nature of the cannabis industry.

Portfolio Pulse from Benzinga Insights

January 05, 2024 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.